These gain-of-function ADAMTS13 variants were more resistant to inhibition by autoantibodies from idiopathic TTP patients because of reduced binding by anti-ADAMTS13 IgGs [158]. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.